Searching the Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
Well-defined PtNi nanocrystals represent one of the most efficient electrocatalysts to boost the oxygen reduction reaction (ORR), especially in the shape of octahedrons, nanoframes, and nanowires. However, the synthesis of complex PtNi nanostructure is still a great challenge. Herein, we report a new class of PtNi hexapods with high activity and stability toward ORR. The hexapods are prepared by selective capping and simultaneous corrosion. By controlling the oxidative etching, PtNi polyhedrons and nanoparticles are obtained, respectively. The intriguing hexapods are composed of six nanopods with an average length of 12.5 nm. Due to their sharp tips and three-dimensional (3D) accessible surfaces, the PtNi hexapods show a high mass activity of 0.85 A mg Pt - 1 at 0.9 V vs. RHE, which are 5.4-fold higher than commercial Pt/C, also outperforming PtNi polyhedrons and PtNi nanoparticles. In addition, the mass activity of PtNi hexapods maintains 92.3% even after 10,000 potential cycles.
Pubmed ID: 30338256
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
American chemical, life science and biotechnology company owned by Merck KGaA. Merger of Sigma Chemical Company and Aldrich Chemical Company. Provides organic and inorganic chemicals, building blocks, reagents, advanced materials and stable isotopes for chemical synthesis, medicinal chemistry and materials science, antibiotics, buffers, carbohydrates, enzymes, forensic tools, hematology and histology, nucleotides, proteins, peptides, amino acids and their derivatives.
View all literature mentions